Bolt Biotherapeutics, Inc. is a biopharmaceutical company based in Redwood City, California, focused on developing innovative immunotherapies for cancer treatment. The company specializes in harnessing the power of the immune system to target and destroy cancer cells, utilizing its proprietary technology platforms to create novel therapeutic candidates. Bolt's research emphasizes the development of antibody-drug conjugates and other targeted therapies, aiming to improve patient outcomes and advance the field of oncology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

11 Patents

#146 in Redwood City, CA

#6,545 in California

#27,540 in US

#51,831 in the World

Redwood City, CA, United States of America

Bolt Biotherapeutics, Inc.

Forward Citations = 7

14 inventors:

Shelley Erin Ackerman (8 out of 8 patents)

Michael Nathaniel Alonso (7 out of 7 patents)

Arthur Lee (6 out of 21 patents)

4. Justin A Kenkel (6 out of 6 patents)

5. Edgar George Engleman (4 out of 46 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bolt Biotherapeutics, Inc.. Retrieved from https://idiyas.com/company/bolt-biotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]